NKX3-1 and prostate carcinoma: In mice, targeted disruption of Nkx3.1 leads to prostatic epithelial hyperplasia and dysplasia [10,11], and over-expression of exogenous NKX3.1 suppresses growth and tumorigenicity in human prostate carcinoma cell lines [12].